Evaluation Of Lunar Test In Average Patient Screening For Colon Cancer
Posted Date: Sep 20, 2021
- Investigator: Loren Brook
- Specialties: Colorectal Cancer, Gastroenterology
- Type of Study: Observational/Survey
The LUNAR-2 blood test has been developed to detect malignant disease in screen-relevant patients who would otherwise undergo screening for malignant disease using invasive methodologies such as colonoscopy. This study will perform a blood draw prior to the patient undergoing the standard of care colonoscopy (and all associated preparatory medications) and retrospectively compare the performance characteristics of the LUNAR-2 test with the findings of the colonoscopy. Outcomes of patients at one and two-years post-procedure will be collected as secondary endpoints.
Key Inclusion: Age 60-84 Years Of Age. Intended To Undergo A Screening Colonoscopy. Considered By Physician To Be Of "Average Risk" For Colorectal Cancer. Willing To Consent To Blood Draw Pre-Bowel Prep For Colonoscopy. Key Exclusion: Undergoing Colonoscopy For Investigation Of Symptoms. Has Undergone Colonoscopy In The Past 9 Years. Completed A Cologuard Test In The Past 3 Year. History Of Malignancy. Known Diagnosis Of Inflammatory Bowel Disease. Family History Of Colorectal Cancer.
Colonoscopy, Screening, Colon Cancer
For More Information: